Acquisition Opportunity Recent acquisition of Cell Science Systems by Genova Diagnostics presents a potential partnership or integration point. Explore post-merger synergies, cross-sell of services, and expanded distribution channels to capitalize on combined customer bases.

Clinical Readiness CLIA certified laboratory, FDA inspected and registered, and cGMP medical device manufacturing with ISO EN13485 alignment indicate strong quality and compliance. Position offerings that leverage high regulatory standards to win work with similarly regulated providers and payer programs.

Immunology Expertise Specialization in immunology and cell biology testing for personalized treatment and chronic disease prevention suggests opportunities for companion diagnostics, treatment monitoring services, and data-driven patient segmentation collaborations with pharma and clinics.

Technology Stack Utilizes cloud and analytics tools (AWS, Optimizely, Google Ads, Hotjar, Piwik PRO) and CRM/marketing platforms (Microsoft 365, Brevo). Leverage this tech footprint to propose scalable telemetry, digital marketing analytics, and secure data exchange solutions for healthcare customers.

Market Positioning Revenue in the lower mid-market segment (approximately $10M-$25M) with a modest employee base. Seek partnerships with mid-sized labs and specialty diagnostics firms seeking growth, distribution expansion, or capability augmentation, leveraging joint marketing and service expansion.